Evidence map›Paper›PMID 25448552›Full record

ArticleInternational journal of pharmaceutics2015

Development of an ultrasound sensitive oxygen carrier for oxygen delivery to hypoxic tissue.

John R Eisenbrey, Lorenzo Albala, Michael R Kramer, Nick Daroshefski, David Brown, Ji-Bin Liu, Maria Stanczak, Patrick O'Kane, Flemming Forsberg, Margaret A Wheatley

Abstract read
In one paragraph

Article in International journal of pharmaceutics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. A Robust Oxygen Microbubble Radiosensitizer for Iodine-125 Brachytherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

John R EisenbreyDepartment of Radiology, Thomas Jefferson University, 132 South 10th Street, Philadelphia, PA 19107, USA. Electronic address: john.eisenbrey@jefferson.edu.
Lorenzo AlbalaSchool of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA 19104, USA.
Michael R KramerDepartment of Radiology, Thomas Jefferson University, 132 South 10th Street, Philadelphia, PA 19107, USA; Temple University School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Nick DaroshefskiSchool of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA 19104, USA.
David BrownSchool of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA 19104, USA.
Ji-Bin LiuDepartment of Radiology, Thomas Jefferson University, 132 South 10th Street, Philadelphia, PA 19107, USA.
Maria StanczakDepartment of Radiology, Thomas Jefferson University, 132 South 10th Street, Philadelphia, PA 19107, USA.
Patrick O'KaneDepartment of Radiology, Thomas Jefferson University, 132 South 10th Street, Philadelphia, PA 19107, USA.
Flemming ForsbergDepartment of Radiology, Thomas Jefferson University, 132 South 10th Street, Philadelphia, PA 19107, USA.
Margaret A WheatleySchool of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA 19104, USA.
Thomas Jefferson University · USDrexel University · USTemple University · US

Funding

DEVELOPMENT OF A NEW CLASS OF ULTRASOUND CONTRAST AGENTSR01HL052901 · NHLBI · DREXEL UNIVERSITY · PI WHEATLEY, MARGARET A. · 1994 to 2009
$1.9M
Vevo 2100 ultrasound scannerS10OD010408 · OD · THOMAS JEFFERSON UNIVERSITY · PI FORSBERG, FLEMMING · 2012 to 2012
$525k
Oxygen Microbubbles for Overcoming Hypoxic Tumor Resistance to RadiotherapyR21CA190926 · NCI · THOMAS JEFFERSON UNIVERSITY · PI EISENBREY, JOHN, O'KANE, PATRICK · 2015 to 2016
$387k
Contrast Enhanced Ultrasound with Therapeutic ModalityR21CA102238 · NCI · DREXEL UNIVERSITY · PI WHEATLEY, MARGARET A · 2003 to 2004
$355k
NCI NIH HHS R21 CA102238NCI NIH HHS R21 CA190926NHLBI NIH HHS R01 HL052901NIH HHS S10 OD010408
6 · The paper itself

Abstract

Radiation therapy is frequently used in the treatment of malignancies, but tumors are often more resistant than the surrounding normal tissue to radiation effects, because the tumor microenvironment is hypoxic. This manuscript details the fabrication and characterization of an ultrasound-sensitive, injectable oxygen microbubble platform (SE61O2) for overcoming tumor hypoxia. SE61O2 was fabricated by first sonicating a mixture of Span 60 and water-soluble vitamin E purged with perfluorocarbon gas. SE61O2 microbubbles were separated from the foam by flotation, then freeze dried under vacuum to remove all perfluorocarbon, and reconstituted with oxygen. Visually, SE61O2 microbubbles were smooth, spherical, with an average diameter of 3.1 μm and were reconstituted to a concentration of 6.5 E7 microbubbles/ml. Oxygen-filled SE61O2 provides 16.9 ± 1.0 dB of enhancement at a dose of 880 μl/l (5.7 E7 microbubbles/l) with a half-life under insonation of approximately 15 min. In in vitro release experiments, 2 ml of SE61O2 (1.3 E8 microbubbles) triggered with ultrasound was found to elevate oxygen partial pressures of 100ml of degassed saline 13.8 mmHg more than untriggered bubbles and 20.6 mmHg more than ultrasound triggered nitrogen-filled bubbles. In preliminary in vivo delivery experiments, triggered SE61O2 resulted in a 30.4 mmHg and 27.4 mmHg increase in oxygen partial pressures in two breast tumor mouse xenografts.

Indexed as

Ultrasonic WavesAnimalsCell Line, TumorDrug CarriersFemaleHumansHypoxiaMice, NudeMicrobubblesNeoplasmsOxygenDrug CarriersOxygenMicrobubbleOxygen deliverySurfactantTumor hypoxiaUltrasound contrast agent

Identifiers

PMID25448552
PMCPMC6457456
OpenAlexW2079153524

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.